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inhibition. Activated mTOR stimulates the 
protein synthesis required for cell growth 
and metabolism through phosphorylation 
of 4E-BP1, eukaryotic elongation factor 2 
kinase, and ribosomal protein S6 kinase 
(p70S6K). These phosphorylated proteins 
assist mRNA translation to proteins by 
promoting capped mRNA to home to a 
ribosome, by enhancing translation elon-
gation, and by maintaining de novo syn-
thesis of S6 ribosomes, respectively (Shaw 
and Cantley, 2006).
Goren et al. (2009) focus on the abil-
ity of active mTORC1 complex to initi-
ate mRNA translation. Active mTORC1 
phosphorylates 4E-BP1, which inhibits its 
association with the cap-binding protein 
eukaryotic translation initiation factor 4E 
(EIF4E). The uncoupling of the 4E-BP1/
EIF4E complex allows the association 
of EIF4E with EIF4G and the initiation 
of cap-dependent translation (Hay and 
Sonenberg, 2004). It is clear from the 
authors’ data that epidermis at the wound 
edge in ob/ob mice demonstrated a pau-
city of VEGF protein from 1 to 5 days after 
wounding and that this defect could be 
reversed by leptin-mediated resolution 
of insulin resistance. It is also clear that 
HaCaT epidermal cell lines stimulated 
with insulin produced increased amounts 
of VEGF protein through an mTOR-
dependent, posttranslational process that 
correlated with increased 4E-BP1 phos-
phorylation. These in vitro data provide 
important and intriguing evidence about 
how the mTOR pathway could control 
VEGF protein production posttranslation-
ally and quite probably how this pathway 
could control the production of other pro-
teins by a similar mechanism. However, it 
is not clear that the paucity of VEGF in the 
nontreated ob/ob wounds was second-
ary to a posttranslational block, because 
VEGF mRNA was not measured in these 
wounds. Perhaps the authors will provide 
a follow-up to this very interesting story.
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A TR(I)P to Pruritus Research:  
Role of TRPV3 in Inflammation and Itch
Martin Steinhoff1 and Tamás Bíró2
Pruritus in eczema and other inflammatory skin diseases is an unsolved problem. 
Recent findings strongly indicate that histamine is not the only mediator of pruri-
tus. Subtypes of the transient receptor potential (TRP) ion channel superfamily are 
expressed by sensory nerves, keratinocytes, and certain leukocytes. Temperature, 
pH changes, and certain toxins activate TRPs. new evidence indicates that the 
vanilloid type 3 (TRPV3) channel is crucially involved in pruritic dermatitis, making 
it a good candidate for future therapy in skin inflammation and pruritus.
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old and new targets in pruritology
Pruritus (itch), perhaps the most com-
mon symptom in dermatology, is associ-
ated with numerous skin diseases, and 
it can be a lead or awkward symptom 
in inflammation and infection, as well 
as with certain tumors. No generally 
accepted treatment regimen exists for 
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pruritus, and many misconceptions and 
controversies prevent optimal treatment 
in this rather neglected but clinically 
and scientifically important area of der-
matology (Paus et al., 2006; Steinhoff 
et al., 2006). Pruritus is modulated at 
the level of peripheral nerves, the dor-
sal root ganglia, the spinal cord, and 
the central nervous system (Figure 1). 
As in pain, different receptors and ion 
channels may employ different activa-
tion mechanisms and the perception of 
itch subtypes. Neuropeptides, neurotro-
phins, amines, cytokines, proteases, 
and prostaglandins are only a part of 
the “pruritic armada” activating spe-
cific receptors on the above-mentioned 
anatomical “branches.” Thus, except for 
histamine-induced itch, a collective of 
itch-inducing agents may be crucial in 
the various diseases, owing to different 
compositions of mediators and recep-
tors (Ikoma et al., 2006).
From daily life, we learn that tem-
perature changes can be linked to 
pain, burning, and pruritus—as well as 
relief of these symptoms by cooling or 
even noxious heating, as experienced 
in urticaria patients. These effects are 
transmitted via primary afferent sensory 
neurons in the dermis and epidermis, 
where they communicate with various 
skin cells. The cell bodies of these neu-
rons are located in cranial or dorsal root 
ganglia (DRG). Upon activation, via the 
spinal cord and contralateral spinotha-
lamic tract, information is transported 
to pain or itch “centers,” triggering the 
body’s defense mechanisms, such as 
withdrawal or scratching.
Sensory nerves are polymodal, 
responding to temperature, mechani-
cal, or chemical stimuli. The different 
subtypes of these polymodal nerve 
fibers must be related to differences in 
the molecular structure; i.e., the specif-
ic receptor repertoire leads to different 
responses. In other words, histamine 
receptors cannot account for every 
pruritic experience in all skin diseases, 
because histamine receptors are not the 
only crucial receptor family in every 
polymodal nerve fiber of itchy derma-
toses. That is where other receptors/
channels, such as the TRP channel fam-
ily, come into play.
Many skin cells are equipped with 
neuronal receptors—e.g., keratinocytes, 
Merkel cells, Langerhans cells, mast 
cells, and endothelial cells—emphasiz-
ing the complexity of the signaling loops 
in the induction and modulation of pru-
ritic responses. Recently, TRP channels 
have entered the stage as temperature 
sensors in the skin; however, additional 
discoveries implicate TRP channels in 
pain and pruritus, as well as immune 
modulation and even immune defense. 
Moreover, certain TRP channels may 
be activated on keratinocytes during 
scratching. This Commentary focuses on 
the TRPV channel subfamily, although 
TRPM8 and TRPA1 are also candidates 
in pruritus and dermatitis research.
the trP ion channel superfamily
The TRP superfamily is composed of 
seven subfamilies: TRPC (canonical), 
TRPV (vanilloid), TRPM (melastatin), 
TRPN (nomp), TRPA (ankyrin), TRPP 
(polycystin), and TRPML (mucolipin) 
Their functions are markedly diverse, 
including sensory transduction of vision, 
taste, olfaction, mechanosensation, and 
thermosensation (Nilius et al., 2007). 
These channels are composed of six pre-
dicted transmembrane domains, where 
they form homo- or heterotetrameric 
complexes. Six channels have been 
shown to play a regulatory role with 
respect to thermo/mechanical/chemi-
cal transmission in the skin (TRPV1, -2, 
-3, and -4: “heat channels”; TRPM8 and 
TRPA1: “cold channels”).
|TRPV3, a novel target for pruritus therapy.
Figure 1. Mediators and sensitization pattern of nociceptive and pruriceptive neurons in the 
skin. Sensitizing and activating mediators in the skin target receptors on primary afferent nerve fibers 
involved in itch and pain processing. During inflammation, mechanoinsensitive “sleeping” nociceptors 
and itch histamine-sensitive mechanoinsensitive pruriceptors and probably mechanosensitive 
pruriceptors transmit the response to the spinal cord. In the spinal cord, noxious input can induce 
central sensitization for pain, and pruriceptive input can provoke central sensitization for itch. Via 
the contralateral tractus spinothalamicus, the stimuli from primary afferent sensory nerves will be 
transmitted to specific areas in the central nervous system. In mice and humans, keratinocytes express 
transient receptor potential vanilloid (TRPV) 1, 3, and 4. In dorsal root ganglia (DRG) neurons, mice 
generate TRPV1, -2, and -4, whereas human DRG also synthesizes TRPV3. TRPV2 is expressed by mast 
cells. CGRP, calcitonin gene–related peptide; CLR, C-type lectin receptor; Ins3P, inositol-3-phosphate; 
PACAP, pituitary adenylate cyclase–activating polypeptide; PKA, protein kinase A; PLC, phospholipase 
C; SP, substance P; VIP, vasoactive intestinal polypeptide.
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trPV ion channels: promising targets  
for antipruritic therapy?
TRPV channels 1–4 display distinct 
thermal activation thresholds and are 
chemosensitive to natural as well as 
synthetic compounds, many of which 
evoke pain and/or pruritus. Thus, TRPVs 
can be activated by exogenous as well 
as endogenous trigger factors as “dan-
ger sensors,” including inflammatory 
stimuli/mediators such as [H+], osmotic 
changes, prostaglandins, certain lipids, 
and endocannabinoids. Together, TRPV 
channels may account for sensations 
such as pruritus (alloknesis) and pain 
(hyperalgesia, allodynia) in human skin.
The best-known member of the 
TRPV family is TRPV1 (Nilius et al., 
2007; Paus et al., 2006). Certain itch 
mediators (e.g., eicosanoids, histamine, 
bradykinin, ATP, and various neu-
rotrophins) activate/sensitize TRPV1, 
eliciting its endovanilloid functions, as 
do heat (>43 oC) and acidosis. Vanilloid 
administration results in a depletion of 
neuropeptides (such as substance P) 
in sensory fibers, which suspends the 
interplay between skin sensory neurons 
and mast cells. Indeed, topical capsai-
cin suppresses histamine-induced itch 
and is increasingly used in the therapy 
of pruritus in numerous skin diseases 
(reviewed in Steinhoff et al., 2006). 
However, functional TRPV1 channels 
are also expressed by numerous non-
neuronal cell types, including human 
epidermal and hair follicle keratino-
cytes, dermal mast cells, and dendritic 
cells. Accordingly, TRPV1 activation 
affects keratinocyte proliferation, dif-
ferentiation, and apoptosis, in addition 
to the release of pruritogenic cytokine 
mediators from these nonneuronal 
cells.
From the above information, one may 
hypothesize that physical and chemical 
mediators are capable of activating/sen-
sitizing TRPV channels on itch-specific 
sensory neurons (sensitization) and skin 
cells to regulate the release of prurito-
genic substances. Consequently, thera-
peutically promising antagonists to TRPV 
channels may desensitize neuronal and 
nonneuronal TRPV1-mediated signal-
ing, thereby counteracting pruritogenic 
intercellular signaling.
trPV3: a novel thermochemical sensor 
in the skin
Among TRPVs, TRPV3 is expressed 
in rodents and humans, activated by 
innocuous warming temperatures (≥33 
oC), and blocked by ruthenium red 
(Figure 2). After stimulation, TRPV3 
currents are voltage dependent and 
biphasic, and sensitization occurs dur-
ing the initial phase, followed by a 
second phase of high-current ampli-
tude in which outward rectification is 
lost (Chung et al., 2005). Interestingly, 
TRPV3 can be activated by chemicals 
such as plant-derived skin sensitizers 
(e.g., eugenol, thymol, and carvac-
rol—major components of oregano, 
savory, clove, and thyme), camphor, 
and 2-APB (Chung et al., 2004). 
Neurophysiological data indicate that 
TRPV3 contributes to an increased 
sensitivity toward repeated physi-
cal and/or chemical stimuli. In vivo 
studies using TRPV3 gene–deficient 
mice indicate a major or exclusive role 
for TRPV3 in thermosensation because 
heat responses but not other sensory 
stimuli were markedly diminished in 
TRPV3–/– mice (Moqrich et al., 2005).
In mice, TRPV3 was not detected in 
DRG neurons, but it was detected in 
keratinocytes (Peier et al., 2002). It was 
therefore hypothesized that keratino-
cytes are important for thermosensa-
tion (Moqrich et al., 2005) (Figure 3). 
Moreover, several mutant rodent strains 
bearing mutant TRPV3, such as the 
autosomal dominant DS-Nh (no-hair) 
mouse and the WBN/Kob-Ht rat, are 
spontaneously hairless (Kochukov et 
al., 2006) and develop atopic derma-
titis (AD)–like lesions (Asakawa et al., 
2006). These two strains express a point 
mutation in the S4–S5 linker of the 
TRPV3 channel (G573S in DS-Nh and 
G573C in WBN/Kob-Ht mice), which is 
highly expressed in keratinocytes and 
other skin cells surrounding hair fol-
licles (Moqrich et al., 2005). In accor-
dance, (subtle) hair abnormalities can 
be observed in TRPV3 knockout mice 
as well (Moqrich et al., 2005), indicat-
ing a crucial role for TRPV3 in hair reg-
ulation and dermatitis. Furthermore, the 
correlation of TRPV3 function as a non-
selective Ca2+-permeable channel and 
the delicate Ca2+ regulation in kerati-
nocyte proliferation and differentiation 
indicates an additional role for this 
channel in skin barrier function.
In primates, however, TRPV3 expres-
sion can be also observed in DRG, 
trigeminal sensory neurons, hypothala-
mus, and several nonneuronal tissues 
(Xu et al., 2002). In human DRGs, 
TRPV3 was coexpressed with TRPV1, 
and it probably interacts with this 
channel (Smith et al., 2002). In human 
breast epithelium, TRPV3 immunoreac-
tivity is restricted to epithelial cells and 
nerve staining is negative (Gopinath 
et al., 2005). In sum, evidence from 
transgenic mouse models, primates, 
and humans indicates that TRPV3 is 
involved in defective environmental 
thermosensation, hairlessness, and 
atopic (itchy) dermatitis (Yoshioka et 
al., 2009).
Yoshioka et al. describe the potential 
impact of TRPV3 in the develop-
ment of allergic and pruritic derma-
titis in mice (Figure 3). This group has 
Figure 2. Schematic depiction of transient 
receptor potential vanilloid (TRPV) channels 
1 and 3. Each channel subunit is made up of 
six putative transmembrane domains with a 
pore region between segments 5 and 6. The 
N- and C-termini are located intracellularly. 
All thermoTRPs except TRPM8 have a variable 
number of ankyrin repeat domains in the 
N-terminus. The C-termini of TRPs also contain 
special features, such as a TRP box or PDZ-
binding domain. TRPV1 and -3 display distinct 
thermal thresholds. Both TRPVs are activated 
by specific botanicals and endogenous and 
synthetic substances, some of which induce 
cutaneous thermal and pain sensations. 2-APB, 
2-aminoethoxydiphenyl borate; NADA, 
N-arachidonoyl-dopamine; PDZ, postsynaptic 
density protein, Drosophila disc large tumor 
suppressor, zonula occudens-1 protein;  
RTX, resiniferatoxin.
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previously shown that the gain-of-
function mutation (G573S) of the trpv3 
gene (TRPV3Gly573Ser) in keratinocytes 
is responsible for the development 
of a spontaneous hairless phenotype 
and pruritic, AD-like skin alterations 
in DS-Nh mice (Asakawa et al., 2006; 
Imura et al., 2007). As a follow-up to 
that study, they generated TRPV3Gly573Ser 
transgenic DS mice with a putative 
promoter sequence in the 5′ region 
of TRPV3 and then assessed the role of 
TRPV3 in the development of specific 
types of dermatitis.
TRPV3Gly573Ser  transgenic mice (highly 
expressing the mutant TRPV3, mostly in 
epidermal keratinocytes and in the testes), 
raised under Staphylococcus aureus–free 
conditions for several weeks, spontane-
ously developed characteristic signs of 
dermatitis, including erythema, edema, 
dry skin, skin erosions, and excoriations 
(wild-type DS littermates did not display 
this phenotype). Histologically, pachy-
derma, hyperkeratosis, and infiltration 
of high numbers of mast cells and CD4+ 
T lymphocytes were observed in skin 
lesions from transgenic mice, showing 
alterations similar to those in human AD. 
Furthermore, as revealed by serological 
analyses, serum levels of total IgE, various 
chemokine ligands, and certain interleu-
kins (IL-13, IL-17), which were suggested 
to play key roles in the development of 
allergic and inflammatory diseases such 
as AD (Purwar et al., 2006), were mark-
edly elevated in TRPV3Gly573Ser  mice. In 
addition, tissue levels of nerve growth 
factor (NGF), which is also an important 
factor in the pathogenesis of human AD 
and pruritus (Paus et al., 2006; Steinhoff et 
al., 2006; Toyoda et al., 2002), as well as 
nerve densities, were significantly higher 
in skin samples of TRPV3Gly573Ser  trans-
genic mice than in wild-type animals. 
Of further importance, the production of 
NGF in epidermal sheets of TRPV3Gly573Ser 
transgenic mice was significantly high-
er in response to physiological (33 oC) 
skin temperature challenges. In accor-
dance with these findings, TRPV3Gly573Ser 
transgenic mice exhibited significantly 
increased scratching behavior compared 
with DS mice, suggesting the spontane-
ous development of pruritus.
Intriguingly, when measuring the 
penetrance of the TRPV3Gly573Ser gene 
for dermatitis and pruritus in a newly 
constructed C57BL-Nh mouse model, 
Yoshida et al. (2009) found that, although 
the TRPV3Gly573Ser gene caused a thicken-
ing of the epidermis, increased numbers 
of skin mast cells and extension of nerves 
to epidermal keratinocytes and, of great 
importance, highly increased scratch-
ing behavior, these mice did not devel-
op spontaneous AD-like dermatitis. It is 
assumed that the lack of dermatitis was 
due to the specific T helper 1 response of 
C57BL mice, which are resistant to aller-
gen stimulation.
It is concluded, therefore, that gain-of-
function of TRPV3 is essential in causing 
allergic and pruritic dermatitis in rodents; 
however, in certain mouse strains, it may 
be insufficient (alone) for the spontane-
ous development of AD-like conditions. 
Therefore, it is proposed that TRPV3 may 
represent a previously unrecognized 
therapeutic target in human pruritic 
(inflammatory) dermatoses.
conclusion and perspectives
It has become apparent that timely 
combination approaches are needed 
that target both the peripheral produc-
tion of inflammation-induced itch sig-
nals and the peripherally incited circles 
that perpetuate itch and cause spinal 
and central sensitization to itch. Thus, 
the combination of peripherally active, 
anti-inflammatory agents with drugs 
that counteract chronic central itch sen-
sation is a sensible approach beyond the 
limited horizon of antihistamine use.
Although additional studies are war-
ranted to define the role of TRPV3 in 
human skin neurophysiology (especial-
ly in the pathogenesis of itch) as well as 
in cutaneous immunobiology, the work 
by Yoshioka and coworkers shows that 
TRPV3 channels are promising candi-
dates for the development of innovative 
and effective itch-management tech-
niques. Because TRPV3 was found in 
both sensory afferents (in primates and 
humans) and skin cells (in rodents), it is 
envisaged that pharmacological manip-
ulation (probably inhibition) of TRPV3 
channel activity may equally lead to the 
cessation of itch signal transmission to 
the central nervous system, as well as 
cessation of the peripheral production 
and release of pruritogenic substances 
(e.g., NGF, interleukins) from epider-
mal keratinocytes and possibly other 
skin cells. In addition, because the skin 
expression of TRPV3 is very similar to 
Figure 3. Potential role of TRP channels mediating thermal, chemical, and mechanical stimuli in the skin. 
Stimuli can stimulate sensory nerve endings and/or keratinocytes via transient receptor potential vanilloid 
(TRPV) channels. Free sensory nerve endings are located in the skin (left) and are coupled via the dorsal 
root sensory ganglia to the spinal cord for further information processing to the central nervous system. 
Physical and chemical stimuli can directly activate TRP channels in the free sensory nerve endings, 
causing depolarization of these fibers, activation of voltage-gated NaV, CaV channels, and generation of 
action potentials (right). TRPV3 and TRPV4 are expressed in murine and human keratinocytes, from which 
signal transduction to the dorsal root ganglia neurons originates. AP, action potential; TRPM8, transient 
receptor potential melastatin 8; TRPA1, transient receptor potential ankyrin 1.
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and substance P are useful plasma markers 
of disease activity in atopic dermatitis. Br J 
Dermatol 147:71–9
Xu H, Ramsey IS, Kotecha SA, Moran MM, Chong 
JA, Lawson D et al. (2002) TRPV3 is a calcium-
permeable temperature-sensitive cation 
channel. Nature 418:181–6
Xu H, Blair NT, Clapham DE (2005) Camphor 
activates and strongly desensitizes the transient 
receptor potential vanilloid subtype 1 channel in 
a vanilloid-independent mechanism. J Neurosci 
25:8924–37
Yoshioka T, Imura K, Asakawa M, Suzuki M, 
Oshima I, Hirasawa T et al. (2009) Impact of 
the Gly573Ser substitution in TRPV3 on the 
development of allergic and pruritic dermatitis 
in mice. J Invest Dermatol 129:714–22
heat-sensitive TRP channel expressed in 
keratinocytes. Science 296:2046-–9
Purwar R, Werfel T, Wittmann M (2006) IL-13-
stimulated human keratinocytes preferentially 
attract CD4+CCR4+ T cells: possible role 
in atopic dermatitis. J Invest Dermatol 
126:1043–51
Smith GD, Gunthorpe MJ, Kelsell RE, Hayes 
PD, Reilly P, Facer P et al. (2002) TRPV3 is a 
temperature-sensitive vanilloid receptor-like 
protein. Nature 418:186–90
Steinhoff M, Bienenstock J, Schmelz M, Maurer 
M, Wei E, Biro T (2006) Neurophysiological, 
neuroimmunological, and neuroendocrine basis 
of pruritus. J Invest Dermatol 126:1705–18
Toyoda M, Nakamura M, Makino T, Hino T, Kagoura 
M, Morohashi M (2002) Nerve growth factor 
that of TRPV1 (another putative target 
molecule in mitigating itch) and, fur-
thermore, because certain skin sensi-
tizing, TRPV3-activating agents (e.g., 
camphor) may also act on TRPV1 (Xu et 
al., 2005), it is proposed that combined 
approaches targeting both TRPV1 and 
TRPV3 may prove advantageous in the 
management of pruritus.
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Selection and Validation of 
Candidate Housekeeping Genes for 
Studies of Human Keratinocytes—
Review and Recommendations
Michael Bär1, Dorit Bär2 and Bodo Lehmann1
Gene expression analysis using real-time PCR has become an integral part of 
biomedical research. Appropriate data normalization based on stably expressed 
housekeeping genes is crucial for reliable results. Thus, candidate housekeeping 
genes require careful evaluation with regard to the individual experimental sys-
tem before being selected for studies of human keratinocytes. Future research 
may be based on published data, as provided by Minner and Poumay in this issue.
Journal of Investigative Dermatology (2009), 129, 535–537. doi:10.1038/jid.2008.428 
Transcriptional regulation is an important 
factor in cellular responses. As a conse-
quence, analysis of gene expression pro-
files has become an integral part of bio-
medical research, including the field of 
dermatology. Currently, real-time quan-
titative reverse transcription PCR (qPCR) 
is the method of choice for specific and 
highly sensitive expression profiling of 
selected groups of target genes. Despite 
being a powerful technique, qPCR suf-
fers from certain pitfalls, with inappro-
priate data normalization remaining one 
of its most important problems. To date, 
the use of so-called housekeeping genes 
(HKGs) is the gold standard by which to 
normalize the mRNA fractions of inter-
est. Usually, these HKGs are among the 
cellular maintenance genes that regulate 
basic and ubiquitous cellular functions or 
code for components of the cytoskeleton 
(β-actin), major histocompatibility com-
plex (β2-microglobulin, B2M), glycolytic 
pathway (glyceraldehyde-3-phosphate 
dehydrogenase, GAPDH, and phos-
phoglycerokinase 1, PGK1), metabolic 
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